Pharmacy

Your Article Summary

See Latest Articles

Pharmacoeconomic Analysis of Reported Use of ENTEREG (alvimopan) Published in American Journal of Health-System Pharmacy
Adolor Corporation, 09/01/09

Adolor Corporation and GlaxoSmithKline announced that an economic analysis of Phase 3 clinical trial data reported that the use of ENTEREG after bowel resection surgery decreased the amount of time patients spent in the hospital by one day, resulting in lower estimated hospital costs compared with placebo. The results, published in the American Journal of Health–System Pharmacy, were based on a post–hoc pharmacoeconomic analysis of pooled data consisting of 1,409 patients who participated in four randomized, double–blind, placebo–controlled, Phase 3 efficacy studies of ENTEREG conducted in North America.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09

See All of Drug Trials

Today in Pharmacoeconomics...keeping you current

Receive free subspecialty "5-minute updates" via email

Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents. A Cost-Effectiveness Analysis
Annals of Internal Medicine, 11/03/09

Societal cost of rheumatoid arthritis patients in the US
Current Medical Research and Opinion, 11/13/09

Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation
Current Medical Research and Opinion, 11/13/09

See All of Pharmacoeconomics